A detailed history of Wfa Asset Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Wfa Asset Management Corp holds 7,003 shares of ABBV stock, worth $1.23 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
7,003
Previous 6,948 0.79%
Holding current value
$1.23 Million
Previous $1.19 Billion 16.04%
% of portfolio
0.75%
Previous 0.67%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $9,011 - $10,963
55 Added 0.79%
7,003 $1.38 Billion
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $9,906 - $11,568
64 Added 0.93%
6,948 $1.19 Billion
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $2,557 - $2,913
-16 Reduced 0.23%
6,884 $1.25 Billion
Q4 2023

May 24, 2024

BUY
$137.6 - $154.97 $10,044 - $11,312
73 Added 1.07%
6,900 $1.07 Billion
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $10,044 - $11,312
73 Added 1.07%
6,900 $1.07 Billion
Q3 2023

May 24, 2024

SELL
$133.59 - $154.65 $7,614 - $8,815
-57 Reduced 0.83%
6,827 $1.02 Billion
Q3 2023

Oct 13, 2023

BUY
$133.59 - $154.65 $10,687 - $12,372
80 Added 1.19%
6,827 $1.02 Billion
Q2 2023

Oct 13, 2023

SELL
$132.51 - $164.9 $3,842 - $4,782
-29 Reduced 0.43%
6,747 $909 Million
Q1 2023

Oct 13, 2023

BUY
$144.61 - $166.54 $9,544 - $10,991
66 Added 0.98%
6,776 $1.08 Billion
Q4 2022

Oct 13, 2023

BUY
$138.31 - $165.87 $8,298 - $9,952
60 Added 0.9%
6,710 $1.08 Billion
Q3 2022

Oct 13, 2023

BUY
$134.21 - $153.93 $18,655 - $21,396
139 Added 2.13%
6,650 $892 Million
Q2 2022

Oct 13, 2023

BUY
$137.62 - $174.96 $28,624 - $36,391
208 Added 3.3%
6,511 $997 Million
Q1 2022

Oct 13, 2023

SELL
$131.98 - $163.75 $5,543 - $6,877
-42 Reduced 0.66%
6,303 $1.02 Billion
Q4 2021

Oct 13, 2023

BUY
$107.43 - $135.93 $681,643 - $862,475
6,345 New
6,345 $859 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wfa Asset Management Corp Portfolio

Follow Wfa Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wfa Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Wfa Asset Management Corp with notifications on news.